Retrospective review of maternal HIV viral load electronic gatekeeping codes in South Africa
Siphesihle K. Mahanjana, Tladi Ledibane, Gayle G. Sherman, Tanya Y. Murray, Ahmad F. Haeri Mazanderani

TL;DR
This study examines the use of electronic gatekeeping codes for maternal HIV viral load testing in South Africa and finds that while uptake improved over time, it remains low, especially for adolescent girls and young women.
Contribution
The study provides the first programmatic monitoring of maternal HIV viral load suppression rates using electronic gatekeeping codes in South Africa.
Findings
National maternal eGK code uptake was 41.8% antenatally, 24.5% at delivery, and 0.12% postnatally in 2022.
Maternal HIV viral load suppression rates were 86.7% antenatally and 87.2% during delivery.
Adolescent girls and young women had lower average suppression rates (76.1% antenatally and 79.6% during delivery).
Abstract
Maternal electronic gatekeeping (eGK) codes for HIV viral load (VL) testing of pregnant and breastfeeding women were developed to permit increased frequency of maternal HIV VL testing without automated gatekeeping cancellation, and to enable virological surveillance. This study describes the national uptake of maternal eGK codes and VL suppression (VLS) rates disaggregated by age during antenatal, delivery and postnatal periods in South Africa during 2022. HIV VL tests associated with C#PMTCT (used for antenatal and postnatal testing) and C#DELIVERY (used at delivery) eGK codes between 01 January and 31 December 2022, were extracted from the National Institute for Communicable Diseases Data Warehouse. Uptake of eGK codes was calculated using indicators from the District Health Information System as denominators while HIV VLS rates (< 1000 copies/mL) were calculated as monthly and…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV/AIDS Research and Interventions · HIV/AIDS Impact and Responses · HIV, Drug Use, Sexual Risk
